Wed, 20 Jun 2012 | BUSINESS SALE
Alliance Boots is to sell a 45 per cent stake to its US larger equivalent Walgreens for $6.5 billion in a tie-up that Stefano Pessina, head of Boots, has wanted for a long time.
The deal is to take place in two stages and may lead to Walgreens becoming the outright owner of Boots, the chemist retail chain with 2,500 shops and 116,000 staff, set up in 1849.
Mr Pessina told the Financial Times, “I have done a deal to make Boots more visible, more international, to create a lot of new markets for Boots and for [the manufacturing facility in] Nottingham… Boots will thrive, not [just] survive.” He also asserted that Boots will not change as a result of the deal.
Walgreens will hand over $4 billion in cash and $2.5 billion in shares for the 45 per cent stake in Boots. And in the second stage of the deal will be able to purchase the remaining 55 per cent for $4.9 billion in cash and 144.3 million shares worth $4.3 billion.
Walgreens, established in 1901, operates almost 8,000 pharmacies in the US, with a workforce of 247,000, and is the largest drugstore chain in the country in terms of revenue, reporting $72 billion last year.
The US group will gain a worldwide presence via Boots’ stores and wholesale distribution operations.
Represents an opportunity for a buyer seeking an integrated health centre pharmacy located in a Liverpudlian established community.
The company is a provider of traffic management solutions, supporting construction and utilities projects in the London area.
Offering for sale a Wirral based integrated health centre pharmacy with scope for further expansion.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.